CII has prepared a research report ‘Boosting India’s Pharmaceutical Exports’ which undertakes a Revealed Comparative Advantage (RCA) analysis to identify India’s pharmaceutical products, at the HS 6-digit level, with high potential or high competitive advantage in the world, that would help bolster Indian trade and investments in the sector. A modified RCA index is used to analyse the competitive advantage of Indian pharmaceutical products with respect to the global pharmaceutical space.
The paper also identifies the potential export destinations for India in the world for these products and provides a broad overview of the Indian Pharma Industry including recent trends and patterns, along with the policies and incentive schemes that are in place currently.